| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 948.00K | 750.00K | 574.00K | 638.00K | 33.00K | 12.00K |
| Gross Profit | -456.00K | -438.00K | -150.00K | 197.00K | -63.00K | -9.00K |
| EBITDA | -4.83M | -5.81M | -3.34M | -2.41M | -1.15M | -797.00K |
| Net Income | -4.45M | -6.13M | -3.48M | -1.94M | -907.00K | -832.00K |
Balance Sheet | ||||||
| Total Assets | 3.62M | 2.54M | 2.27M | 667.00K | 428.00K | 138.00K |
| Cash, Cash Equivalents and Short-Term Investments | 915.00K | 261.00K | 117.00K | 91.00K | 18.00K | 9.00K |
| Total Debt | 2.73M | 2.75M | 2.52M | 170.00K | 860.00K | 115.00K |
| Total Liabilities | 3.77M | 4.09M | 4.27M | 335.00K | 914.00K | 127.00K |
| Stockholders Equity | -159.00K | -1.55M | -2.00M | 62.00K | -786.00K | 17.00K |
Cash Flow | ||||||
| Free Cash Flow | -4.06M | -6.34M | -2.78M | -2.09M | -1.29M | -557.00K |
| Operating Cash Flow | -3.81M | -5.93M | -2.59M | -1.97M | -1.28M | -545.00K |
| Investing Cash Flow | -387.50K | -399.00K | -189.00K | -116.00K | -9.00K | -12.00K |
| Financing Cash Flow | 2.25M | 6.47M | 2.80M | 2.16M | 1.30M | 536.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £447.89M | 11.44 | 12.72% | 7.01% | 8.58% | -15.81% | |
70 Outperform | £1.10B | 19.11 | 12.23% | 0.79% | 7.74% | 30.09% | |
64 Neutral | £1.37B | 36.79 | 5.88% | 2.52% | 0.59% | -41.66% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
47 Neutral | £24.14M | -5.12 | -1427.02% | ― | 147.18% | 3.11% | |
47 Neutral | £3.17M | -1.07 | -94.96% | ― | 15.00% | -592.50% |
MicroSalt plc has announced the allotment of 341,527 ordinary shares following the exercise of stock options, with these shares expected to begin trading on AIM on or around 26 November 2025. This move increases the total number of ordinary shares with voting rights to 52,304,803, reflecting the company’s ongoing efforts to enhance its market presence and shareholder engagement. The exercise of options and subsequent share issuance underscores MicroSalt’s strategic initiatives to strengthen its financial position and expand its influence in the burgeoning low-sodium salt market.
MicroSalt has announced a positive trading update, with unaudited sales reaching $1.66 million for the first ten months of 2025, surpassing initial revenue expectations. The company has strengthened its relationship with a major North American customer, projecting significant sales growth in 2026 and 2027, and has signed a non-binding term sheet for a Joint Development Agreement to reduce sodium content in food products. Additionally, MicroSalt has formed a strategic partnership with Daiya Foods, further boosting its sales projections for the coming years. These developments underscore MicroSalt’s strategic efforts to build a sustainable organization focused on delivering healthier food options and enhancing investor returns.
MicroSalt plc has announced a strategic partnership with Daiya Foods, a leader in dairy-free and plant-based food innovation. This collaboration marks a significant expansion for MicroSalt, integrating its low-sodium salt into Daiya’s product lines, particularly focusing on cheese and pizza dough. The partnership is expected to enhance MicroSalt’s presence beyond the snack sector, reinforcing its position as a preferred partner for global food manufacturers aiming to meet the rising consumer demand for healthier, full-flavour products. This move aligns with the global trend towards sodium reduction, potentially impacting both companies’ market reach and consumer offerings.
MicroSalt PLC reported significant financial and operational progress in the first half of 2025, achieving record revenue of $0.8 million, a substantial increase from the previous year. The company reduced its net loss and expanded its market presence in the UK and Belgium, while strengthening its sales pipeline with major food manufacturers. The successful launch of MicroSalt® Premium and strategic focus on bulk ingredient sales have positioned the company for sustained financial improvements. Looking ahead, MicroSalt anticipates significant sales growth with new product lines and increased demand from multinational FMCG companies, indicating a promising outlook for the coming years.